Coldstream Laboratories Names Director of Formulation Development
Adrian Raiche, Ph.D. Named as Director of Formulation Development at Coldstream Laboratories, Inc.
LEXINGTON, KY--(Marketwired – November 18, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.
In this position, Dr. Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization and scale-up activities for manufacturing in the company’s sterile manufacturing facility.
Dr. Raiche brings to Coldstream expertise in numerous aspects of pharmaceutical development, particularly lyophilization and potent compound handling. Most recently, he served as Manager of Pharmaceutical Development at Summit Biosciences contributing to formulation, analytical and process development of nasal spray products. Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals and Bausch and Lomb. Dr. Raiche holds a Ph.D. in Biomedical Engineering, a Master of Science in Biomedical Engineering, and a Bachelor of Science in Chemical Engineering, all from the University of Kentucky.
"We are pleased with Dr. Raiche’s addition to the Coldstream team,” said Coldstream President and CEO Eric Smart. "His knowledge of process and product development enhances Coldstream’s focus on the development of parenterals, especially our emphasis on highly active compounds.”
Coldstream Laboratories, Inc., based in Lexington, KY, is a privately held specialty pharmaceutical contract manufacturing organization. Coldstream operates Kentucky’s only parenteral manufacturing